These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 21369933)
1. A combined molecular modeling study on a series of pyrazole/isoxazole based human Hsp90α inhibitors. Yang Y; Liu H; Du J; Qin J; Yao X J Mol Model; 2011 Dec; 17(12):3241-50. PubMed ID: 21369933 [TBL] [Abstract][Full Text] [Related]
2. 3D-QSAR, molecular docking, and molecular dynamic simulations for prediction of new Hsp90 inhibitors based on isoxazole scaffold. Abbasi M; Sadeghi-Aliabadi H; Amanlou M J Biomol Struct Dyn; 2018 May; 36(6):1463-1478. PubMed ID: 28482755 [TBL] [Abstract][Full Text] [Related]
3. Combined 3D-QSAR modeling and molecular docking study on 1,4-dihydroindeno[1,2-c]pyrazoles as VEGFR-2 kinase inhibitors. Zeng H; Zhang H J Mol Graph Model; 2010 Aug; 29(1):54-71. PubMed ID: 20471293 [TBL] [Abstract][Full Text] [Related]
4. An in silico exploration of the interaction mechanism of pyrazolo[1,5-a]pyrimidine type CDK2 inhibitors. Li Y; Gao W; Li F; Wang J; Zhang J; Yang Y; Zhang S; Yang L Mol Biosyst; 2013 Sep; 9(9):2266-81. PubMed ID: 23864105 [TBL] [Abstract][Full Text] [Related]
5. Towards the In-silico Design of New HSP90 Inhibitors: Molecular Docking and 3D-QSAR CoMFA Studies of Tetrahydropyrido [4, 3-d] Pyrimidine Derivatives as HSP90 Inhibitors. Sepehri B; Ghavami R Med Chem; 2018; 14(5):439-450. PubMed ID: 29564982 [TBL] [Abstract][Full Text] [Related]
6. 3D QSAR pharmacophore, CoMFA and CoMSIA based design and docking studies on phenyl alkyl ketones as inhibitors of phosphodiesterase 4. Gaurav A; Singh R Med Chem; 2012 Sep; 8(5):894-912. PubMed ID: 22741782 [TBL] [Abstract][Full Text] [Related]
7. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies. Hou T; Zhu L; Chen L; Xu X J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563 [TBL] [Abstract][Full Text] [Related]
9. CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site. Buolamwini JK; Assefa H J Med Chem; 2002 Feb; 45(4):841-52. PubMed ID: 11831895 [TBL] [Abstract][Full Text] [Related]
10. Docking-based CoMFA and CoMSIA studies on naphthyl-substituted diarylpyrimidines as NNRTIs. Wu HQ; Yao J; He QQ; Chen FE SAR QSAR Environ Res; 2014; 25(10):761-75. PubMed ID: 25242254 [TBL] [Abstract][Full Text] [Related]
11. Structural determination of three different series of compounds as Hsp90 inhibitors using 3D-QSAR modeling, molecular docking and molecular dynamics methods. Liu J; Wang F; Ma Z; Wang X; Wang Y Int J Mol Sci; 2011 Jan; 12(2):946-70. PubMed ID: 21541036 [TBL] [Abstract][Full Text] [Related]
13. CoMFA and CoMSIA 3D-QSAR analysis of diaryloxy-methano-phenanthrene derivatives as anti-tubercular agents. Shagufta ; Kumar A; Panda G; Siddiqi MI J Mol Model; 2007 Jan; 13(1):99-109. PubMed ID: 16858589 [TBL] [Abstract][Full Text] [Related]
14. Multi-conformation 3D QSAR study of benzenesulfonyl-pyrazol-ester compounds and their analogs as cathepsin B inhibitors. Zhou Z; Wang Y; Bryant SH J Mol Graph Model; 2011 Sep; 30():135-47. PubMed ID: 21798778 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues. Sharp SY; Prodromou C; Boxall K; Powers MV; Holmes JL; Box G; Matthews TP; Cheung KM; Kalusa A; James K; Hayes A; Hardcastle A; Dymock B; Brough PA; Barril X; Cansfield JE; Wright L; Surgenor A; Foloppe N; Hubbard RE; Aherne W; Pearl L; Jones K; McDonald E; Raynaud F; Eccles S; Drysdale M; Workman P Mol Cancer Ther; 2007 Apr; 6(4):1198-211. PubMed ID: 17431102 [TBL] [Abstract][Full Text] [Related]
16. Prediction of new Hsp90 inhibitors based on 3,4-isoxazolediamide scaffold using QSAR study, molecular docking and molecular dynamic simulation. Abbasi M; Sadeghi-Aliabadi H; Amanlou M Daru; 2017 Jun; 25(1):17. PubMed ID: 28666484 [TBL] [Abstract][Full Text] [Related]
17. 2D and 3D-QSAR analysis of pyrazole-thiazolinone derivatives as EGFR kinase inhibitors by CoMFA and CoMSIA. Pourbasheer E; Aalizadeh R; Shiri HM; Banaei A; Ganjali MR Curr Comput Aided Drug Des; 2015; 11(4):292-303. PubMed ID: 26548551 [TBL] [Abstract][Full Text] [Related]
18. 3D-QSAR study of Chk1 kinase inhibitors based on docking. Zhao L; Liu Y; Hu S; Zhang H J Mol Model; 2012 Aug; 18(8):3669-94. PubMed ID: 22367634 [TBL] [Abstract][Full Text] [Related]
19. Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking. Sun G; Fan T; Zhang N; Ren T; Zhao L; Zhong R Molecules; 2016 Jun; 21(7):. PubMed ID: 27347909 [TBL] [Abstract][Full Text] [Related]
20. In silico QSAR studies of anilinoquinolines as EGFR inhibitors. Pasha FA; Muddassar M; Srivastava AK; Cho SJ J Mol Model; 2010 Feb; 16(2):263-77. PubMed ID: 19590909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]